Jonathan Brett
Professor; Senior Research Fellow; Senior Staff Specialist in Clinical Pharmacology, Toxicology and Addiction Medicine
Data updated
Research Footprint
Jonathan Brett appears in 5 tracked papers (2024–2026), most studied alongside Psilocybin and Ketamine, across Depressive Disorders, Substance Use Disorders (SUD) and Anxiety Disorders.
Most-cited paper: Who Are You After Psychedelics? A Systematic Review and a Meta-Analysis of the Magnitude of Long-Term Effects of Serotonergic Psychedelics on Cognition/Creativity, Emotional Processing and Personality (16 citations).
Frequent co-authors: Paul Liknaitzky, Gillinder Bedi and Nathalie Mason.
Background & Research
Jonathan Brett is a Senior Research Fellow at UNSW Sydney’s School of Population Health and a senior staff specialist in clinical pharmacology, toxicology and addiction medicine at St. Vincent’s Hospital Sydney. His research spans neuropsychopharmacology, drugs of abuse, medicines use in pregnancy, and clinical trials of psychedelic-assisted psychotherapy.
Key Impact
He is a leading Australian clinical pharmacologist and addiction medicine researcher with a substantial publication record in psychedelic-assisted psychotherapy and methamphetamine use disorder.
Collaboration Network
5 collaborators· click a node to visit their profile
Full network →Collaboration Network
See Jonathan Brett's full collaboration network, shared papers, and research connections.
Compounds
Topics
Top Collaborators
Top Collaborators
Unlock clinical summaries, full texts, and related trial mapping.